Literature DB >> 6457135

A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.

I Fogelman, D W Pearson, R G Bessent, A J Tofe, M D Francis.   

Abstract

Twenty normal volunteers had measurements of 24-hr whole-body retention (WBR) of three structurally related Tc-99m-labeled phosphonate skeletal imaging agents: (1-hydroxyethylidene) diphosphonate (HEDP), methylene diphosphonate (MDP), and hydroxymethylene diphosphonate (HMDP). The average WBR values, reflecting skeletal uptake, were 18.4, 30.3, and 36.6%, respectively. These results clearly illustrate that slight alterations in diphosphonate molecular structure have a significant effect upon specificity for osseous tissue, and thus may affect skeletal image quality and the usefulness of the WBR technique in diagnosing metabolic bone disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457135

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

Review 1.  Rationale for the use of alendronate in osteoporosis.

Authors:  J A Kanis; B J Gertz; F Singer; S Ortolani
Journal:  Osteoporos Int       Date:  1995-01       Impact factor: 4.507

Review 2.  Bisphosphonates and the treatment of bone disease in the elderly.

Authors:  A Johansen; M Stone; F Rawlinson
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

3.  Clinical comparison of 99mTc-HMDP and 99mTc-MDP. A multicenter study.

Authors:  B Delaloye; A Delaloye-Bischof; R Dudczak; K Koppenhagen; F Mata; A Penafiel; F D Maul; J Pasquier
Journal:  Eur J Nucl Med       Date:  1985

4.  Diphosphonates in the evaluation of metabolic bone disease.

Authors:  I Fogelman; M L Smith
Journal:  Clin Rheumatol       Date:  1982-03       Impact factor: 2.980

5.  Diphosphonate bone scanning agents--current concepts.

Authors:  I Fogelman
Journal:  Eur J Nucl Med       Date:  1982

Review 6.  Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.

Authors:  F A de Jonge; E K Pauwels; N A Hamdy
Journal:  Eur J Nucl Med       Date:  1991

7.  Synthesis and biological evaluation of novel (99m)Tc-labelled bisphosphonates as superior bone imaging agents.

Authors:  Ling Qiu; Wen Cheng; Jianguo Lin; Shineng Luo; Li Xue; Jing Pan
Journal:  Molecules       Date:  2011-07-25       Impact factor: 4.411

8.  Mechanism of bisphosphonate-related osteonecrosis of the jaw (BRONJ) revealed by targeted removal of legacy bisphosphonate from jawbone using competing inert hydroxymethylene diphosphonate.

Authors:  Hiroko Okawa; Takeru Kondo; Akishige Hokugo; Philip Cherian; Jesus J Campagna; Nicholas A Lentini; Eric C Sung; Samantha Chiang; Yi-Ling Lin; Frank H Ebetino; Varghese John; Shuting Sun; Charles E McKenna; Ichiro Nishimura
Journal:  Elife       Date:  2022-08-26       Impact factor: 8.713

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.